medicine-news-1/veran-medical-technologies-announces-intellectual-property-agreement-with-medtronic-47443-1/;msg18067;topicseen

Breaking Biology Technology:Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2 Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3 Martek Signs Sole-Source Supply Agreement with Fonterra 2 Martek Signs Sole-Source Supply Agreement with Fonterra 3 La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 2 La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert 3 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6

[0] Brooks Instrument Appoints Mike Bayda as Global Level Product Manager [0] Martek Signs Sole-Source Supply Agreement with Fonterra [0] La Jolla Pharmaceutical Company - Value Play or Overvalued: TapeBeat.Com Trader Alert [0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain

Breaking Medicine Technology:DecisionView Launches StudyOptimizer(TM) 4 2 DecisionView Launches StudyOptimizer(TM) 4 3 The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9 Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10 Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 1 Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 2 Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 3 Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4659 4 Natural born divers and the molecular traces of evolution 9035 1 Natural born divers and the molecular traces of evolution 9035 2 Reading the brain without poking it 9033 1 Reading the brain without poking it 9033 2 Reading the brain without poking it 9033 3 Reading the brain without poking it 9033 4 Reading the brain without poking it 9033 5

[0] DecisionView Launches StudyOptimizer(TM) 4 [0] The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies [0] Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection